aTYR PHARMA (ATYR) Enterprise Value (2015 - 2026)
aTYR PHARMA (ATYR) reported Enterprise Value of $1.24 million for Q2 2026, down 99.7% from $390.32 million a year earlier and down 87.3% from the prior quarter.
Powered by 
Analysis
aTYR PHARMA (ATYR) Enterprise Value (2015 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, aTYR PHARMA's Enterprise Value came in at -$234.16 million; for FY2025, it was -$2.41 million.
- By year, Enterprise Value came in at $231.91 million in FY2024, -$9.12 million in FY2023, -$1.72 million in FY2022 and $34.45 million in FY2021 (+834.4%).
- Five-year quarterly Enterprise Value spans a low of -$26.58 million in Q1 2023 and a high of $390.32 million in Q2 2025.
- Year over year, Enterprise Value gained in two of the last four quarters, with growth averaging 246.8%.
- The high point for year-over-year Enterprise Value in five years was Q2 2025 (growth of 886.3%); the low point was Q2 2026 (a decline of 99.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $9.77 million (Q1 2026), -$2.41 million (Q4 2025) and -$19.84 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | aTYR PHARMA | 16.81 Mn | -276.01 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.24 Mn |
| Mar 31, 2026 | 9.77 Mn |
| Dec 31, 2025 | -2.41 Mn |
| Sep 30, 2025 | -19.84 Mn |
| Jun 30, 2025 | 390.32 Mn |
| Mar 31, 2025 | 192.25 Mn |
| Dec 31, 2024 | 231.91 Mn |
| Sep 30, 2024 | 67.25 Mn |
| Jun 30, 2024 | 39.58 Mn |
| Mar 31, 2024 | 48.61 Mn |
| Dec 31, 2023 | -9.12 Mn |
| Sep 30, 2023 | -9.79 Mn |
| Jun 30, 2023 | 14.45 Mn |
| Mar 31, 2023 | -26.58 Mn |
| Dec 31, 2022 | -1.72 Mn |
| Sep 30, 2022 | 9.48 Mn |
| Jun 30, 2022 | -9.13 Mn |
| Mar 31, 2022 | 51.26 Mn |
| Dec 31, 2021 | 34.45 Mn |
| Sep 30, 2021 | 48.36 Mn |
API Access
aTYR PHARMA Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=ATYR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "ATYR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=ATYR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();